OR WAIT null SECS
© 2021 MJH Life Sciences and Pharmaceutical Executive. All rights reserved.
© 2021 MJH Life Sciences™ and Pharmaceutical Executive. All rights reserved.
Julian Upton is Pharmaceutical Executive's Online and European Editor. He can be reached at firstname.lastname@example.org
New drug aims to turn obesity into treatable chronic condition.
Teva CEO Kåre Schultz talks about his long industry experience tackling major strategic and operational challenges, and how he is progressing on his current mission to turn around Teva’s fortunes.
Digital transformation in medical affairs made a sluggish start, but there is plenty to be optimistic about.
AstraZeneca’s Mina Makar and Amgen’s Kave Niksefat talk about how the two companies worked together to develop the new asthma treatment, tezepelumab.
Accelerated implementation of AI platforms among pharma sales teams has highlighted the importance of the human factor.
GSK‘s President of US Pharmaceuticals, Maya Martinez-Davis, outlines her organization’s evolving diversity and inclusion commitments.
Along with the industry’s massive effort to tackle the health and social problems exposed by COVID, pharma companies have spent the last year addressing the internal impact of racial inequalities following the murder of George Floyd.
Alnylam's new Chief Commercial Officer, Tolga Tanguler, talks about his new role and what he envisions for the company in the next five years.
Our editorial team presents the winners of our annual Emerging Pharma Leaders and their up-and-coming perspectives on a range of industry topics.
Nick Stephens talks to Pharm Exec about how the highs and lows of the executive search business in the last 12 months.